98%
921
2 minutes
20
Background: Starting dialysis is associated with morbidity and mortality. Outcomes for people with failed transplants can be poorer than for people with native kidney failure. We aimed to determine whether dialysis modality, place of initiation and mortality outcomes differed in the first 90 days between people starting dialysis for transplant and native kidney failure.
Methods: Retrospective cohort using linked UK Renal Registry data and Hospital Episode Statistics. Modality, place of initiation and outcomes compared with Day 90 for 16 417 adults starting dialysis in England between January 2018 and December 2019.
Results: Relative to those with native kidney failure (90.6%), those with transplant failure (9.4%) were younger (median 55.2 vs 66.3 years) and commenced more in-centre haemodialysis [86.8% vs 82.2%, adjusted odds ratio (OR) 1.72, 95% confidence interval (CI) 1.47-2.01; < .0001]. Compared with individuals reported to have native chronic kidney disease, and accounting for age, sex, diabetes and ethnicity, those with transplant failure had increased odds of starting dialysis in hospital (adjusted OR 2.26, 95% CI 1.84-2.76; < .0001), at higher estimated glomerular filtration rates (eGFRs) (8.9 vs 7.9 mL/min/1.73 m²; = .0001), and death [adjusted OR 1.95, 95% CI 1.31-2.90; = .001).
Discussion: UK patients starting dialysis for transplant failure do so at higher eGFRs than those receiving specialist chronic kidney disease care. Those with transplant failure appear disproportionately likely to start as inpatients, receive haemodialysis or die within 90 days. These findings are likely to reflect differences between both patient groups and care pathways. Deeper understanding may inform improvements in care.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12146846 | PMC |
http://dx.doi.org/10.1093/ckj/sfaf158 | DOI Listing |
Background: Acute kidney injury (AKI) in patients with liver cirrhosis represents a significant clinical challenge with high mortality rates. This study aimed to develop and validate a machine learning-based prediction model for 28-day mortality in AKI patients with liver cirrhosis using the MIMIC-IV database.
Methods: This retrospective study analyzed data from 4,168 AKI patients, including 601 with concurrent liver cirrhosis, from the MIMIC-IV database.
Blood Purif
September 2025
Selected Abstracts from the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology.
View Article and Find Full Text PDFESC Heart Fail
September 2025
Division of Heart Failure and Transplant, Mayo Clinic in Florida, Jacksonville, Florida, USA.
Background: Patients with end-stage heart failure and chronic kidney disease requiring dual-organ transplantation (DOT) face significant challenges in utilizing durable mechanical circulatory support due to the risks associated with renal replacement therapies (RRTs) and multi-organ failure. Given the limited options available for long-term support in this patient population, there remains a critical need for alternative strategies to optimize end-organ function and bridge patients safely to transplant. With prolonged waitlist times for DOT, we present our experience with the Impella 5.
View Article and Find Full Text PDFJ Am Soc Nephrol
September 2025
AP-HP, Nephrology Department, European Georges Pompidou Hospital, Paris, France.
Clin J Am Soc Nephrol
September 2025
Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.